# LINZESS
> **NDA202811** · New Drug Application · Sponsor: ABBVIE · Approved 2012-08-30
## Drug
- **FDA Application Number:** NDA202811
- **Application type:** New Drug Application
- **Brand name:** LINZESS
- **Generic name:** LINACLOTIDE
- **Active ingredients:** LINACLOTIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** Allergan, Inc.
- **First approval:** 2012-08-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202811)
---
*AI Analytics · CC0 1.0*